Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Swarmer Publishes Letter From Its Chairman, Erik Prince, Outlining Strategy
-
Quantum Cyber Entering Steady-State Scale Production, Launches Vertically Integrated Advanced Filament Manufacturing Division
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
In tomorrow’s AI economy, what’s the role of humans?
-
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
-
Toobit Rewards Traders with VIP Benefits and Over 1,000 USDT
-
The World Cup Effect: Superprof Survey Finds American Families Are Getting Excited About World Cultures
-
Labrador Gold to Host Investor Webinar on the Mariposa Gold Project in Yukon’s White Gold District
-
Kyivstar’s Uklon Launches Marketplace, Starting with Flower Delivery
-
Xali Gold Announces Non-Brokered Financing
-
Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy
-
Joveo Named Strategic Challenger on 2026 Fosway 9-Grid™ for Talent Acquisition
-
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
-
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
-
Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Cl
-
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
-
Troilus Continues to Expand High-Grade West Rim Discovery With 19.06 g/t AuEQ Over 6.4 m and 6.81 g/t AuEQ Over 5 m at Surface
-
Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window
-
GURU Organic Energy Delivers 31.6% Revenue Growth and Continued Margin Expansion in Second Quarter 2026
-
Lithium Ionic Initiates Long-Lead Order and Provides Community Engagement Update
-
Edibles.com Names Thomas Winstanley President to Drive Next Phase of Growth
-
Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026
-
Aqua Metals Selected as Industrial Partner on DOE-Funded Idaho National Laboratory Program Advancing Critical Minerals Refining
-
Verano Completes 1-for-5 Reverse Stock Split, Advancing the Company’s Path Towards Prospective U.S. Stock Exchange Listing
-
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pret
-
BrewDog Rolls Back Pint Prices to £2 Across Scotland for 72-Hour Bank Holiday Weekend, Celebrating the National Team’s Return
-
The Lovesac Company Reports First Quarter Fiscal 2027 Financial Results
-
Neion Bio Raises Oversubscribed $23 Million Series A to Advance Biologics Manufacturing Platform and Expand Pipeline
-
Bereaved Mothers Give a Gift to Every Grieving Father: The “All Fathers Day” Free Grief Support Bundle. A Documentary Film. A Live Father’s Day Support Group. Free Online Courses. A Dedicated Co
-
BlossomHill Therapeutics Presents Initial Clinical Data from Dose Escalation in Ongoing Phase 1/1b Trial of Novel Macrocyclic CLK Inhibitor, BH-30236, in Patients with R/R AML or HR-MDS at EHA 2026
-
Kyivstar’s Uklon Launches Marketplace, Marking Strategic Entry into E-Commerce and Accelerating Ecosystem Monetization
-
Impact Analytics Honored as 2026 “Demand Forecasting Solution of the Year” for the Second Consecutive Year, by SupplyTech Breakthrough
-
AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease
-
Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026
-
Havila Kystruten AS: Annual General Meeting 2026 held
-
Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia
-
Pharvaris Announces Annual General Meeting of Shareholders
-
Kimco Realty OP, LLC Announces Pricing of Upsized $525.0 Million Exchangeable Senior Notes Offering
-
MSX Launches X Card, Bridging Digital Assets and Global Consumer Payments
-
BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.76 Billion in 2026
-
BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.76 Billion in 2026
-
Agencia Comercial Spirits Ltd Announces Power Supply Agreements with PLN for Indonesia AI Data Center Project
-
CORRECTION -- Mysti's Adult and Family Services Begins Statewide Rental Assistance Program Under Washington's Health-Related Social Needs Initiative
-
First Atlantic Highlights U.S. Dominance Act Passed by House: New Critical Minerals Bill Authorizes Equity Investment, Co-Financing, and U.S.-Priority Offtake for Allied Projects and Defines “Proces
-
Compass Diversified Announces CEO Succession Plan
-
Parsons Awarded $22M Contract for Los Angeles’ I-605 Multimodal Corridor Improvements
-
Regulatory release no. 6 - 2026: New long-term share-based incentive programme
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Form 8.5 (EPT/RI)-NCC Group Plc
-
Documentary decodes millennia-old Tibetan medicinal bathing
